Physician profile
Charles E Wadsworth
NPI 1316903719
$477.07
in general payments reported to CMS, 2019-2025
12 companies · $204 in 2025
The $204 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $140 · 2022: $35.08 · 2023: $59.50 · 2024: $39.13 · 2025: $204.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $302.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $302.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $203.54 | 2025 | Xtandi |
| Abbvie INC. | $60.21 | 2023-2024 | |
| Antares Pharma, INC. | $43.84 | 2021 | |
| Dendreon Pharmaceuticals LLC | $34.57 | 2021 | |
| Endo Pharmaceuticals INC. | $32.09 | 2021-2023 | Edex, Aveed, Xiaflex |
| Procept Biorobotics Corporation | $19.93 | 2024 | Aquabeam System |
| Cardinal Health 414 LLC | $18.89 | 2022 | |
| Sun Pharmaceutical Industries INC. | $16.19 | 2022 | |
| Merck Sharp & Dohme LLC | $14.70 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.71 | 2021 | |
| Teleflex LLC | $11.69 | 2021 | |
| Clarus Therapeutics INC. | $7.71 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Wadsworth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.